Utilizing Immunosequencing in Cancer Research & Drug Discovery
Adaptive Biotechnologies’ immunoSEQ® Technology is an end-to-end immunosequencing solution capable of profiling millions of B- and T-cell receptors at high throughput and providing a quantitative view into the immune repertoire.
This presentation provides:
- An overview of the immunoSEQ Technology.
- Highlighting key use cases of the immunoSEQ Technology in oncology research.
- Applications in pre-clinical and clinical research settings.
- An overview of Adaptive’s drug development capabilities, including identifying and characterizing viable therapeutic targets in solid tumors.
immunoSEQ is For Research Use Only. Not for use in diagnostic procedures.
Patrick Raber, PhD
Adria Carbo, PhD
Register for SEQdiscovery
To access this webinar and all other SEQdiscovery content.
If you have previously registered and opted to have an account please log in above.